Carla
Rios Luci
Publicaciones en las que colabora con Carla Rios Luci (8)
2020
-
Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms
Cancer Letters, Vol. 470, pp. 161-169
2019
-
TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells
Cancer Letters, Vol. 453, pp. 34-44
2018
-
A Small Molecule Tubulin Depolymerizing Agent Identified by a Phenotypic Drug Discovery Approach
Journal of Molecular and Clinical Medicine, Vol. 1, Núm. 2, pp. 67-76
2017
-
Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity
Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651
2012
-
β-Lapachone analogs with enhanced antiproliferative activity
European Journal of Medicinal Chemistry, Vol. 53, pp. 264-274
2011
-
A modular approach to trim cellular targets in anticancer drug discovery
Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 22, pp. 6641-6645
2010
-
Enhancement of antiproliferative activity by molecular simplification of catalpol
Bioorganic and Medicinal Chemistry, Vol. 18, Núm. 7, pp. 2515-2523
-
Mitotic arrest induced by a novel family of DNA topoisomerase II inhibitors
Journal of Medicinal Chemistry, Vol. 53, Núm. 9, pp. 3835-3839